Prevent Heart Disease in HIV

What we are studying

The main purpose of this clinical trial is to see if pitavastatin can prevent heart disease and heart-related deaths in people with HIV infection who are taking HIV medications. We will also study the safety of pitavastatin.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 40 - 75

Eligibility Criteria

  • HIV infected
  • On antiretroviral therapy (ART) for at least 6 months prior to study entry
  • CD4+ cell count >100
  • Must not be pregnant and must agree not to become pregnant during the study
  • No history of cardiovascular disease (history of heart attack or stroke etc.)
  • No history of cancer in the last 3 years
  • Not currently using a statin drug

What is involved

  • Visits to the clinic 6 times the first year and then every 4 months until study completion
  • Blood draws
  • Ecgs
  • Pregnancy tests
  • Questionnaires


You will be paid $25 for each completed study visit

Contact Information

Study Coordinator
Keisa Williamson
Principal Investigator
Aimee Wilkin, MD, MPH

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.